Page 98 - DUOKOPT BIBLIOBOOK

DUOKOPT - bibliography book - CONFIDENTIAL - document for exclusive use by personnel of Laboratoires Théa – DO NOT DISTRIBUTE
®

KEY MESSAGES

‐ 1 month study (15 patients) evaluating DTFC on IOP, visual function and ocular hemodynamics.
‐ Intraocular pressure was significantly reduced by dorzolamide-timolol combination as compared with
timolol alone.

STRENGTHS

X The dorzolamide-timolol combination accelerated superior temporal arterial arterio-
venous passage of fluorescein dye as compared with timolol treatment alone, from 2.13
to 1.76 seconds.

X DTFC reduces the amount of time required for blood to pass through the superior retinal
vasculature.

WEAKNESSES

X Low number of patients (15).

MARKETING CLAIM

X Dorzolamide-Timolol combination reduces IOP and increases ocular blood flow
compared to Timolol.

98